J

James Keaney

UCB Pharma (Belgium)

26 papers and 1.8k citations.

PubIndex Score49Top 51% · mid-careerHow it's scored

26Publications

1.8kTotal Citations

First publication: 2010First senior author: 2019

Top publicationsby citations

Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways

Julie Langlois, James Keaney|Journal of Neuroinflammation|2024

Cited by 18

Indexing the rest of 26 publications…